CN1120007C - Medicine for treating mastopathy - Google Patents
Medicine for treating mastopathy Download PDFInfo
- Publication number
- CN1120007C CN1120007C CN00113950A CN00113950A CN1120007C CN 1120007 C CN1120007 C CN 1120007C CN 00113950 A CN00113950 A CN 00113950A CN 00113950 A CN00113950 A CN 00113950A CN 1120007 C CN1120007 C CN 1120007C
- Authority
- CN
- China
- Prior art keywords
- medicine
- mammary
- mastopathy
- present
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a pure Chinese medical preparation for treating all kinds of mastopathy, which is proportionally prepared from gecko, scorpion, centipede, prunella ball, caladium and cat claw buttercup root. The present invention has satisfactory therapeutic effects on mammary hyperplasia, mammary fibroma, mammary duct ectasia, mammary tumors and early mammary cancer. Simultaneously, the present invention has certain effects on tracheophyma and hysteromyoma.
Description
The invention belongs to a kind of pharmaceutical product, particularly a kind of is the pure Chinese medicinal preparation of raw material treatment woman mammary gland disease with animals and plants.
Mammary glands in women is a kind of common frdquently encountered disease, and doctor trained in Western medicine adopts the excision means, and is not only painful but also easily bring some negative effects.The treatment by Chinese herbs medicine that is seen in the report is seldom general, but the ubiquity compatibility of drugs is too much, and is too complicated, and generally is at a kind of symptom and compatibility.It is simple not see some compatibilities as yet, can adapt to multiple mastotic Chinese medicine.
It is simple that the object of the invention provides a kind of compatibility, can adapt to multiple mastotic pure Chinese medicinal preparation.
The present invention program:
A kind of medicine that is used for the treatment of mastopathy is characterized in that being made by the raw material of following weight ratio:
Gekko Swinhonis 5-20 Scorpio 5-15 Scolopendra 5-15
Spica Prunellae 50-80 Bulbus Fritillariae Uninbracteatae 20-60 Radix Ranunculi Ternati 10-20
The preferential prescription of recommending of the present invention is to be made by the raw material of following weight ratio:
Gekko Swinhonis 15 Scorpios 10 Scolopendras 10
Spica Prunellae 60 Bulbus Fritillariae Uninbracteataes 40 Radix Ranunculi Ternatis 15
The present invention prescription has been avoided the weak point of a large amount of drug for invigorating blood circulation and eliminating stasis, goes into to faint behind the cloudy gas with XIAKUQIU, and the gas that logical blood network stagnates, clear going up mended down, takes all medicines and reaches focus.Carry Scolopendra, Scorpio, Gekko Swinhonis, Radix Ranunculi Ternati to eliminate blood stasis, search and pick meridians, resolving mass and removing the obstruction of the collateral; Bulbus Fritillariae Uninbracteatae is with clearing away heart-fire and moistening the lung, clearing and dissipating phlegm-heat, the dry property of its warm medicine of bitter cold system; Only Gekko Swinhonis has the mosquito of engulfing nature, the doctor trained in Western medicine chemical analysis is thought and is contained all necessary aminoacid and nonessential aminoacid of human body in the Gekko Swinhonis tissue fluid, clinical intractable headache, neurasthenia, stain infections disease, fracture, the dermatosis etc. of being used for, the traditional Chinese medical science have dispel the wind, the effect of arresting convulsion, active, detoxifcation.Therefore side's group medicine letter effect is prompt, has certain biological response modifier sample effect, has no side effect, and takes the adaptability height for a long time.But the doctor that can not give up deposits medicine and develops.For improving curative effect of the present invention and adaptability, dialectical by theory of Chinese medical science based on this side to mastopathy, filter out and have the higher medicine of biological response modifier sample effect, make its collaborative collateral dredging apophlegmatisant focus of going directly.The hard person of sucutaneous nodule matter can increase the weight of removing blood stasis repercussive medicine; Stagnation of QI Sheng person can increase the weight of the strongly fragrant medicine of circulation of qi promotingization; The axil lymph swells and ache and jeopardizes upper limb, can increase the weight of tying-in, blood-activating analgesic; The phlegm-damp victor does not forget the dampness removing that reduces phlegm, totally should focus on " monarch " medicine return through so that the clinical efficacy of medicine improves.
Medicine for treating mastopathy is a kind of pure Chinese medicinal preparation for oral administration, can largely improve the cure rate of mastopathy, can make the patient avoid hardship of performing the operation and the negative effect of performing the operation and bringing.Reach early stage breast carcinoma at various cyclomastopathy, mammary gland fibroma, mammary duct ectasia, mastadenoma sampleization, simultaneously thyromegaly, hysteromyoma are had certain effect.This prescription is selected pure natural combination for use, has no side effect, and the adaptability height, effect is remarkable, but to specificity allergic constitution and the part cardiac taboo of taking medicine.
The present invention is applied to for many years clinical, and is as follows according to the clinical observation report that some cases is summed up:
1. diagnostic criteria:
According to patient's clinical diagnosis, assist the diagnosis of near infrared ray breast scanner and B-mode ultrasound tomography.
2. efficacy determination classification:
(1) recovery from illness: mastalgia and lump complete obiteration.
(2) produce effects: under inducements such as preceding, anger, the mastalgia degree obviously alleviates before the treatment, and the lump volume-diminished is over half, and slight tenderness is arranged.
(3) effective: treatment back pain is more preceding to be alleviated to some extent, the deliquescing of lump quality, volume-diminished is not enough half.
(4) invalid: after the treatment, symptom and sign fail to improve, even increase the weight of.
3. efficacy analysis brief summary:
The present invention is through the various hypertrophy 378 routine patients of clinical treatment mammary gland, and efficacy analysis is as follows: age group is in 17-62 year, healing 127 examples in 2 weeks wherein, effective 378 people, produce effects 364 people.4 week-6 week is added up cure rate 96.5%, obvious effective rate 97.3%, effective percentage 100%.
It is as follows that mammary gland fibroma is observed 124 routine patient's efficacy analysis: the age is wherein cured 83 examples in 4 weeks in 19-56 year, produce effects 96 examples, effective 124 examples, 4 week-8 week statistics, cure rate 72.9%, obvious effective rate 90.3%, effective percentage 100%.
126 routine patients observe as follows to mammary duct ectasia: age group is in 24-57 year, and medication is cured 91 examples in 4 weeks, produce effects 109 examples, effective 126 examples, 4-8 week statistics cure rate 91.5%, obvious effective rate 94.3%, effective percentage 100%.
The mastadenoma sampleization is reached early stage breast carcinoma observes 240 examples and be analyzed as follows: the age is cured 198 examples, produce effects 204 examples, effective 215 examples, 4-8 week statistics, cure rate 85.4%, obvious effective rate 91%, effective percentage 96.9% in 21-65 year in 4 weeks.
4. sum up:
(1) the invention solves the drawback that mastopathy tradition medication cure rate is low, recurrent is high, the course of treatment is long.
(2) have medication return through property strong, very strong characteristics of specific aim just.
(3) have two-ways regulation endocrine function to a certain extent, demonstrate according to female skin pigmentation regular variation of degree and menstruation of disappearing.
(4) solved gastrointestinal dysfunction that the mammary gland long term administration causes and (or) patients with gastric disease medication adaptability farthest arranged.
The dose of medicine of the present invention and method: 4 grams (is standard with powder)/time, day clothes three times, administration on an empty stomach should take with yellow wine.
Embodiment 1:
A kind of pure Chinese medicinal preparation-medicine for treating mastopathy that is used for the treatment of multiple mastopathy, make by the raw material of following weight:
Gekko Swinhonis 20 Scorpios 5 Scolopendras 15
Spica Prunellae 50 Bulbus Fritillariae Uninbracteataes 20 Radix Ranunculi Ternatis 20
Said medicine all is unit with the gram, mixes grinding and sieving, makes powder behind the radiosterilization.
Embodiment 2:
The present invention also can be made by the raw material of following weight:
Gekko Swinhonis 15 Scorpios 10 Scolopendras 10
Spica Prunellae 60 Bulbus Fritillariae Uninbracteataes 40 Radix Ranunculi Ternatis 15
Preparation method is with embodiment 1, and flashing becomes ball.
Embodiment 3:
The present invention also can be made by the raw material of following weight:
Gekko Swinhonis 5 Scorpios 15 Scolopendras 5
Spica Prunellae 80 Bulbus Fritillariae Uninbracteataes 60 Radix Ranunculi Ternatis 10
Preparation method is the same.
Claims (2)
1, a kind of medicine that is used for the treatment of mastopathy is characterized in that being made by the raw material of following weight ratio:
Gekko Swinhonis 5-20 Scorpio 5-15 Scolopendra 5-15
Spica Prunellae 50-80 Bulbus Fritillariae Uninbracteatae 20-60 Radix Ranunculi Ternati 10-20.
2, the medicine that is used for the treatment of mastopathy according to claim 1 is characterized in that being made by the raw material of following weight ratio:
Gekko Swinhonis 15 Scorpios 10 Scolopendras 10
Spica Prunellae 60 Bulbus Fritillariae Uninbracteataes 40 Radix Ranunculi Ternatis 15.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN00113950A CN1120007C (en) | 2000-10-23 | 2000-10-23 | Medicine for treating mastopathy |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN00113950A CN1120007C (en) | 2000-10-23 | 2000-10-23 | Medicine for treating mastopathy |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1296826A CN1296826A (en) | 2001-05-30 |
| CN1120007C true CN1120007C (en) | 2003-09-03 |
Family
ID=4583683
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN00113950A Expired - Fee Related CN1120007C (en) | 2000-10-23 | 2000-10-23 | Medicine for treating mastopathy |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1120007C (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10341307A1 (en) * | 2003-09-08 | 2005-03-31 | Toximed Gmbh | Pharmaceutical agent for breast cancer |
| CN105079709A (en) * | 2015-09-15 | 2015-11-25 | 孟令起 | Traditional Chinese medicinal composition for treating lump in breast |
| CN106177725A (en) * | 2016-08-15 | 2016-12-07 | 周建国 | A kind of treat the plaster compositions of mastopathy, purposes and preparation method thereof |
| CN108721574A (en) * | 2018-08-23 | 2018-11-02 | 盐城刘氏健康咨询有限公司 | A kind of medicine for removing tumour object and preparation method thereof |
-
2000
- 2000-10-23 CN CN00113950A patent/CN1120007C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1296826A (en) | 2001-05-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1120007C (en) | Medicine for treating mastopathy | |
| CN100482257C (en) | Zuanshanfeng wind damp oil and its preparation method | |
| CN104000863A (en) | Medicinal composition for treating malignant tumor accompanied with gall-stone and preparation method and medical application thereof | |
| CN1186044C (en) | Chinese medicine 'lidandishi' for treating hepatobiliary calculus and cholecystitis | |
| CN1723956A (en) | Medicine for treating chronic gastritis and gastric carcinoma, and its prepn. method | |
| CN1966008A (en) | Medicated wine for treating cancer and tumor and method for preparing same | |
| CN1899305A (en) | Chinese medicine for treating dermatosis and tumor | |
| CN104435437B (en) | A kind ofly treat Chinese medicine of the concurrent glossopharyngeal neuralgia of trigeminal neuralgia and preparation method thereof | |
| CN101537080B (en) | Pine needle health-care medicinal liquor with efficacy of dispersing pathogenic wind and removing dampness and preparation method thereof | |
| Liu et al. | Clinical Observation on the Improved Short-Term Effects of Anti-Tumor Purified Chinese Medicine Injection Ai-Jing for 138 Cases with Malignant Tumors | |
| CN1236798C (en) | External medicine for treating bone tuberculosis | |
| CN1228977A (en) | Ointment for treating cancer and preparation method thereof | |
| CN103070998B (en) | Externally-applied plaster for curing pain of rheumatic joints | |
| CN1261121C (en) | Medicine for treating constipation, halitosis and gum swelling | |
| CN1216634C (en) | Medicinal composition for treating pain | |
| CN1225271C (en) | Medicine for curing hyperplasia disease of mamary glands | |
| CN103356965A (en) | Drug for curing rheumatoid arthritis | |
| Manjare et al. | A REVIEW ARTICLE ON RAKTAMOKSHAN: A PARASURGICAL PROCEDURE | |
| CN103961547A (en) | Externally-applied traditional Chinese medicinal preparation for treating liver-qi stagnation type mammary gland hyperplasia and nursing method | |
| CN1615969A (en) | Chinese medicine preparation pus drawing out plaster for treating pasteur cystic, furuncle, furunculosis and carbuncle | |
| CN101181473B (en) | Compound maytenfolic splinter | |
| CN1359711A (en) | Anticancer oral liquid and its preparing process | |
| CN1239663A (en) | Chinese medicine preparation for treating rectum cancer, colon cancer and breast cancer | |
| CN1071129C (en) | Pill for relief of choke | |
| CN101843759A (en) | Oral Chinese medicament for treating fracture |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |